FDIC
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) 158.8% HIGHER; announced after the close that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the Associated Professional Sleep Societies 2009 Annual Meeting in Seattle, Washington and also during the European League Against Rheumatism Congress in Copenhagen, Denmark. The data at APSS will be presented on June 10 and June 11 and at EULAR on June 12.
GreenHunter Energy (AMEX: GRH) 111.8% HIGHER; continuing to see investor interest today following yesterday's 63% surge. As the company is involved in the acquisitions of assets in the renewable energy sector, the recent jump may be on the back of rising crude oil, which closed above the $70 mark yesterday for the first time in 7-months.
Lear ...
